About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
E
Melanoma Case Discussion: 83 y/o Female With a Biopsy-Proven Right Forehead Malignant Melanoma
By
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
FEATURING
Emma Hill
,
Kevin Patel
,
Edward Seger
,
Elina Shustef
By
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
FEATURING
Emma Hill
,
Kevin Patel
,
Edward Seger
,
Elina Shustef
38 views
February 29, 2024
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
23:16
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
2023 Updates on Dysplastic Nevi
Feat.
B. Kelley
20:10
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Melanonychia Diagnosis, Evaluation, and Treatment
Feat.
F. Fish
20:09
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Dysplastic Nevi: Navigating the Risk Landscape
Feat.
B. Kelley
12:46
Stanford Medicine
FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …
Feat.
A. Betof Warner
23:09
Total Health
Key Updates in Skin Melanoma
Feat.
R. Seedor
29:26
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Sun Exposure and Melanoma: Connecting the Dots
Feat.
D. Kent
14:25
EADV 2023 Insights
EADV 2023 Insights: Treating Cancer in the Elderly: Minimally Invasi…
Feat.
P. Pasquali
17:39
Melanoma Bridge 2023
Major Emerging Paradigm Shifts That Will Change Melanoma Management …
Feat.
A. Eggermont
24:40
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Pathology of Melanoma
Feat.
B. Kelley
23:57
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Innovations in Diagnostic Techniques for Melanoma
Feat.
T. Blalock
19:52
OncoAlert
Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…
Feat.
A. Betof Warner
21:12
Robert Swerlick
Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?
52:19
Winship Melanoma and Cutaneous Oncology Symposium
2024 Updates on Neoadjuvant Therapy for Resectable Melanoma
Feat.
S. Patel
14:00
Melanoma Bridge 2023
Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…
Feat.
J. Luke
13:12
2023 Year in Review
Year in Review: Surgical Treatment of Acral Melanoma
Feat.
M. Leventer
30:29
NYU Langone
Updates in Treatment with Immunotherapy for Melanoma and Related Mal…
Feat.
J. Weber
25:10
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Immunotherapy Combinations in Melanoma in 2024
Feat.
J. Moyers
20:55
2023 West Oncology Conference
2023 West Oncology Conference: Melanoma Updates
Feat.
M. Mooradian
11:56
Melanoma Bridge 2023
Adjuvant Therapy in Stage II Melanoma: Tools to Balance the Choice
Feat.
P. Ascierto
29:40
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
Melanoma, the Primary Lesion: Biopsy, Excision, and Mohs Surgery in …
Feat.
D. Kent
